Literature DB >> 29171935

Single molecule real-time DNA sequencing of HLA genes at ultra-high resolution from 126 International HLA and Immunogenetics Workshop cell lines.

T R Turner1,2, J D Hayhurst1, D R Hayward1, W P Bultitude1,2, D J Barker1, J Robinson1,2, J A Madrigal1,2, N P Mayor1,2, S G E Marsh1,2.   

Abstract

The hyperpolymorphic HLA genes play important roles in disease and transplantation and act as genetic markers of migration and evolution. A panel of 107 B-lymphoblastoid cell lines (B-LCLs) was established in 1987 at the 10th International Histocompatibility Workshop as a resource for the immunogenetics community. These B-LCLs are well characterised and represent diverse ethnicities and HLA haplotypes. Here we have applied Pacific Biosciences' Single Molecule Real-Time (SMRT) DNA sequencing to HLA type 126 B-LCL, including the 107 International HLA and Immunogenetics Workshop (IHIW) cells, to ultra-high resolution. Amplicon sequencing of full-length HLA class I genes (HLA-A, -B and -C) and partial length HLA class II genes (HLA-DRB1, -DQB1 and -DPB1) was performed. We typed a total of 931 HLA alleles, 895 (96%) of which were consistent with the typing in the IPD-IMGT/HLA Database (Release 3.27.0, January 20, 2017), with 595 (64%) typed at a higher resolution. Discrepant types, including novel alleles (n = 10) and changes in zygosity (n = 13), as well as previously unreported types (n = 34) were observed. In addition, patterns of linkage disequilibrium were distinguished by four-field resolution typing of HLA-B and HLA-C. By improving and standardising the HLA typing of these B-LCLs, we have ensured their continued usefulness as a resource for the immunogenetics community in the age of next generation DNA sequencing.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  B-lymphoblastoid cell lines; HLA; International HLA and Immunogenetics Workshop; SMRT sequencing

Mesh:

Substances:

Year:  2017        PMID: 29171935     DOI: 10.1111/tan.13184

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  21 in total

Review 1.  Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation.

Authors:  Volker M Lauschke; Magnus Ingelman-Sundberg
Journal:  NPJ Genom Med       Date:  2020-03-05       Impact factor: 8.617

2.  Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.

Authors:  Lisa E Creary; Sandra G Guerra; Winnie Chong; Colin J Brown; Thomas R Turner; James Robinson; Will P Bultitude; Neema P Mayor; Steven G E Marsh; Katsuyuki Saito; Kevin Lam; Jamie L Duke; Timothy L Mosbruger; Deborah Ferriola; Dimitrios Monos; Amanda Willis; Medhat Askar; Gottfried Fischer; Chee Loong Saw; Jiannis Ragoussis; Martin Petrek; Carles Serra-Pagés; Manel Juan; Catherine Stavropoulos-Giokas; Amalia Dinou; Reem Ameen; Salem Al Shemmari; Eric Spierings; Ketevan Gendzekhadze; Gerald P Morris; Qiuheng Zhang; Zahra Kashi; Susan Hsu; Sridevi Gangavarapu; Kalyan C Mallempati; Fumiko Yamamoto; Kazutoyo Osoegawa; Tamara Vayntrub; Chia-Jung Chang; John A Hansen; Marcelo A Fernández-Viňa
Journal:  Hum Immunol       Date:  2019-03-04       Impact factor: 2.850

Review 3.  Long-read sequencing in deciphering human genetics to a greater depth.

Authors:  Mohit K Midha; Mengchu Wu; Kuo-Ping Chiu
Journal:  Hum Genet       Date:  2019-09-19       Impact factor: 4.132

4.  Characterization of primary models of human trophoblast.

Authors:  Megan A Sheridan; Xiaohui Zhao; Ridma C Fernando; Lucy Gardner; Vicente Perez-Garcia; Qian Li; Steven G E Marsh; Russell Hamilton; Ashley Moffett; Margherita Y Turco
Journal:  Development       Date:  2021-11-05       Impact factor: 6.868

5.  Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.

Authors:  Angela Lombardi; Erlinda Concepcion; Hanxi Hou; Hanane Arib; Mihaly Mezei; Roman Osman; Yaron Tomer
Journal:  J Autoimmun       Date:  2020-09-17       Impact factor: 7.094

6.  Nanopore sequencing and the Shasta toolkit enable efficient de novo assembly of eleven human genomes.

Authors:  Kishwar Shafin; Trevor Pesout; Ryan Lorig-Roach; Marina Haukness; Hugh E Olsen; Colleen Bosworth; Joel Armstrong; Kristof Tigyi; Nicholas Maurer; Sergey Koren; Fritz J Sedlazeck; Tobias Marschall; Simon Mayes; Vania Costa; Justin M Zook; Kelvin J Liu; Duncan Kilburn; Melanie Sorensen; Katy M Munson; Mitchell R Vollger; Jean Monlong; Erik Garrison; Evan E Eichler; Sofie Salama; David Haussler; Richard E Green; Mark Akeson; Adam Phillippy; Karen H Miga; Paolo Carnevali; Miten Jain; Benedict Paten
Journal:  Nat Biotechnol       Date:  2020-05-04       Impact factor: 54.908

7.  High-resolution HLA allele and haplotype frequencies in several unrelated populations determined by next generation sequencing: 17th International HLA and Immunogenetics Workshop joint report.

Authors:  Lisa E Creary; Nicoletta Sacchi; Michela Mazzocco; Gerald P Morris; Gonzalo Montero-Martin; Winnie Chong; Colin J Brown; Amalia Dinou; Catherine Stavropoulos-Giokas; Clara Gorodezky; Saranya Narayan; Srinivasan Periathiruvadi; Rasmi Thomas; Dianne De Santis; Jennifer Pepperall; Gehad E ElGhazali; Zain Al Yafei; Medhat Askar; Shweta Tyagi; Uma Kanga; Susana R Marino; Dolores Planelles; Chia-Jung Chang; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2021-05-24       Impact factor: 2.211

Review 8.  A long road/read to rapid high-resolution HLA typing: The nanopore perspective.

Authors:  Chang Liu
Journal:  Hum Immunol       Date:  2020-05-01       Impact factor: 2.211

Review 9.  Single molecule real-time (SMRT) sequencing comes of age: applications and utilities for medical diagnostics.

Authors:  Simon Ardui; Adam Ameur; Joris R Vermeesch; Matthew S Hestand
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

Review 10.  HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.

Authors:  Burcu Duygu; Timo I Olieslagers; Mathijs Groeneweg; Christina E M Voorter; Lotte Wieten
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.